![Michael Palfreyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Palfreyman
Director/Miembro de la Junta en
THALIA THERAPEUTICS PLC
.
Perfil
Michael Gavin Palfreyman was the founder of Amorsa Therapeutics, Inc., founded in 2013, where the title held was Chief Scientific Officer from 2013 to 2019.
Dr. Palfreyman is also the founder of Scriptgen Pharmaceuticals, Inc...
Dr. Palfreyman is currently Director at Amakem NV since 2011.
Dr. Palfreyman is currently Independent Non-Executive Director at Thalia Therapeutics Plc since 2024.
Dr. Palfreyman is currently Vice President-Development at Brenig Therapeutics, Inc. Former positions include Chief Operating Officer & Director at Adelia Therapeutics, Inc., Chief Scientific Officer at Marc Pharmaceuticals, Inc., VP-Program Management & Product Development at FORUM Pharmaceuticals, Inc., Principal at Psychiatric Genomics, Inc., Principal at Torrey Pines Investment, Inc., and Chief Research & Development Officer at Cybin, Inc. Education includes a doctorate (1970), graduate degree (1971), and undergraduate degree (1967) from The University of Nottingham.
Cargos activos de Michael Palfreyman
| Empresas | Cargo | Inicio |
|---|---|---|
| THALIA THERAPEUTICS PLC | Director/Miembro de la Junta | 09/09/2024 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Director/Miembro de la Junta | 25/08/2011 |
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Michael Palfreyman.
| Empresas | Cargo | Fin |
|---|---|---|
| CYBIN INC. | Director Técnico/Científico/I+D | 05/06/2023 |
Amorsa Therapeutics, Inc.
 Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuron pharmaceutical company | Fundador | 01/07/2019 |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Fundador | - |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Director de Operaciones | - |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Inversor de Capital Privado | - |
Formación de Michael Palfreyman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
38
Relaciones de 1er grado
12
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Scriptgen Pharmaceuticals, Inc.
Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Marc Pharmaceuticals, Inc.
 Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage pharmaceutical company | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Psychiatric Genomics, Inc.
 Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative small molecule drugs | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Finance |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuron pharmaceutical company | Health Technology |
Cybin, Inc.
 Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
- Bolsa de valores
- Insiders
- Michael Palfreyman
